Cargando…

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

The effects of tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, on weight reduction after successful intensive lifestyle intervention are unknown. This double-blind, placebo-controlled trial randomized (1:1) adults with body mass index ≥30 or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wadden, Thomas A., Chao, Ariana M., Machineni, Sriram, Kushner, Robert, Ard, Jamy, Srivastava, Gitanjali, Halpern, Bruno, Zhang, Shuyu, Chen, Jiaxun, Bunck, Mathijs C., Ahmad, Nadia N., Forrester, Tammy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667099/ https://www.ncbi.nlm.nih.gov/pubmed/37840095 http://dx.doi.org/10.1038/s41591-023-02597-w

Ejemplares similares

Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program
por: le Roux, Carel W., et al.
Publicado: (2022)

OR10-05 Improved Mental And Psychosocial Patient-Reported Outcomes Among People With Obesity Treated With Tirzepatide: Results From SURMOUNT-1 Study
por: Poon, Jiat Ling, et al.
Publicado: (2023)

SAT660 Predictors Of Achieving Body Weight Reduction ≥20% With Tirzepatide In People With Overweight Or Obesity In SURMOUNT-1
por: Srinath, Reshmi, et al.
Publicado: (2023)

SAT658 Tirzepatide Reduces The Predicted Risk Of Developing Atherosclerotic Cardiovascular Disease: A Post-hoc Analysis Of The Surmount-1 Trial
por: Hankosky, Emily R, et al.
Publicado: (2023)

Proposals for Surmounting Sensor Noises
por: Pittella, Andre, et al.
Publicado: (2023)

Tirzepatide: A Systematic Update
por: Forzano, Imma, et al.
Publicado: (2022)

Adverse Events Related to Tirzepatide
por: Mishra, Rahul, et al.
Publicado: (2023)

Tirzepatide for type 2 diabetes
por: Anderson, Sarah L, et al.
Publicado: (2023)

Alcohol Intake and Weight Loss during an Intensive Lifestyle Intervention for Adults with Overweight/Obesity and Diabetes
por: Chao, Ariana M., et al.
Publicado: (2018)

Keeping patients with epilepsy safe: a surmountable challenge?
por: Shankar, Rohit, et al.
Publicado: (2015)

Surmounting structural barriers to tackle endemic infectious diseases
por: Calderón, Felix, et al.
Publicado: (2021)

Advent of tirzepatide: boon for diabetic and obese?
por: Bhusal, Amrit
Publicado: (2023)

Tirzepatide and prevention of chronic kidney disease
por: Bosch, Catalina, et al.
Publicado: (2022)

Tirzepatide-Induced Injection Site Reaction
por: Mizumoto, Junki
Publicado: (2023)

The effects of subcutaneous Tirzepatide on obesity and overweight: a systematic review and meta‐regression analysis of randomized controlled trials
por: Rohani, Pejman, et al.
Publicado: (2023)

Human biomonitoring data interpretation and ethics; obstacles or surmountable challenges?
por: Sepai, Ovnair, et al.
Publicado: (2008)

Baryon decay: flipped SU(5) surmounts another challenge
por: Ellis, Jonathan Richard, et al.
Publicado: (1990)

Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets
por: Onishi, Anne C., et al.
Publicado: (2011)

Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
por: Kanwar, Jagat R, et al.
Publicado: (2012)

Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses
por: Škubník, Jan, et al.
Publicado: (2021)

Tirzepatide—Friend or Foe in Diabetic Cancer Patients?
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor–specified peripheral niche constraints
por: Nishio, Junko, et al.
Publicado: (2010)

Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
por: Donnadieu, Emmanuel, et al.
Publicado: (2020)

Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins
por: Feng, Yiyuan, et al.
Publicado: (2023)

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
por: Wang, Lijing
Publicado: (2022)

Structural determinants of dual incretin receptor agonism by tirzepatide
por: Sun, Bingfa, et al.
Publicado: (2022)

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
por: Anala, Alekya Devi, et al.
Publicado: (2023)

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
por: Quddos, Fatima, et al.
Publicado: (2023)

Epidemiological Data on Heart Rhythm Disorders in India - A Formidable but Surmountable Challenge
por: Hygriv Rao, B
Publicado: (2012)

Successfully Climbing the “STAIRs”: Surmounting Failed Translation of Experimental Ischemic Stroke Treatments
por: Kahle, Michael P., et al.
Publicado: (2012)

Surmounting intrinsic quantum-measurement uncertainties in Gaussian-state tomography with quadrature squeezing
por: Řeháček, Jaroslav, et al.
Publicado: (2015)

Poor-Law Infirmaries in War-Time: How Difficulties Have Been Surmounted
Publicado: (1915)

Immune Suppression in Tumors as a Surmountable Obstacle to Clinical Efficacy of Cancer Vaccines
por: Wieërs, Grégoire, et al.
Publicado: (2011)

Weight loss efficiency and safety of tirzepatide: A Systematic review
por: Lin, Fei, et al.
Publicado: (2023)

Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
por: Sinha, Rachel, et al.
Publicado: (2023)

Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective
por: De Block, Christophe, et al.
Publicado: (2022)

Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond
por: Dutta, Palak, et al.
Publicado: (2023)

Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1–4 Trials
por: Rosenstock, Julio, et al.
Publicado: (2023)

Surmounting difficulties to provide home based neonatal care – reflections of community health workers
por: Prabhughate, Abhijit Shrinivas, et al.
Publicado: (2018)

mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic
por: Chen, Peixian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2q5gqe1rn1f4fl1r4l5m756p76